ici 118551 and gemcitabine

ici 118551 has been researched along with gemcitabine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, K; Liu, H; Ma, Q; Shan, T; Wang, F; Wu, E; Zhang, D1

Other Studies

1 other study(ies) available for ici 118551 and gemcitabine

ArticleYear
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.
    European journal of pharmacology, 2011, Aug-31, Volume: 665, Issue:1-3

    Topics: Adrenergic beta-2 Receptor Antagonists; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Synergism; Gemcitabine; Humans; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta-2

2011